Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MT-ND3 pseudogene 19 (MTND3P19) is a non-coding segment in the human nuclear genome resembling the sequence of the mitochondrial gene MT-ND3, but it does not encode a functional protein, nor is it transcribed or translated for biological activity[2]. Pseudogenes are typically regarded as evolutionary relics from gene duplication or transfer events, and MTND3P19 should not be confused with the protein-coding mitochondrial gene MT-ND3, which is a subunit of respiratory Complex I and implicated in mitochondrial diseases such as Leigh syndrome and MELAS[3][7]. No clinical, therapeutic, or biomarker importance is ascribed to MTND3P19.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MT-ND3 pseudogene 19 (MTND3P19).